KR940003495B1 - 디스타마이신 a유도체의 제조방법 - Google Patents

디스타마이신 a유도체의 제조방법 Download PDF

Info

Publication number
KR940003495B1
KR940003495B1 KR1019860005716A KR860005716A KR940003495B1 KR 940003495 B1 KR940003495 B1 KR 940003495B1 KR 1019860005716 A KR1019860005716 A KR 1019860005716A KR 860005716 A KR860005716 A KR 860005716A KR 940003495 B1 KR940003495 B1 KR 940003495B1
Authority
KR
South Korea
Prior art keywords
compound
formula
alkyl
group
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019860005716A
Other languages
English (en)
Korean (ko)
Other versions
KR870001228A (ko
Inventor
아르카모네 페데리코
몬겔리 니콜라
아니마티 파비오
Original Assignee
팜이탈리아 카를로 엘바 에스.피.에이.
비토리노 페라리오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 팜이탈리아 카를로 엘바 에스.피.에이., 비토리노 페라리오 filed Critical 팜이탈리아 카를로 엘바 에스.피.에이.
Publication of KR870001228A publication Critical patent/KR870001228A/ko
Application granted granted Critical
Publication of KR940003495B1 publication Critical patent/KR940003495B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
KR1019860005716A 1985-07-16 1986-07-15 디스타마이신 a유도체의 제조방법 Expired - Fee Related KR940003495B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8517923 1985-07-16
GB858517923A GB8517923D0 (en) 1985-07-16 1985-07-16 Distamycin derivatives

Publications (2)

Publication Number Publication Date
KR870001228A KR870001228A (ko) 1987-03-12
KR940003495B1 true KR940003495B1 (ko) 1994-04-23

Family

ID=10582358

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860005716A Expired - Fee Related KR940003495B1 (ko) 1985-07-16 1986-07-15 디스타마이신 a유도체의 제조방법

Country Status (29)

Country Link
US (1) US4738980A (enExample)
JP (1) JPH0780842B2 (enExample)
KR (1) KR940003495B1 (enExample)
CN (2) CN85103908A (enExample)
AT (1) AT386822B (enExample)
AU (1) AU584723B2 (enExample)
BE (1) BE905109A (enExample)
CA (1) CA1247627A (enExample)
CH (1) CH671958A5 (enExample)
CZ (1) CZ277823B6 (enExample)
DE (1) DE3623853C2 (enExample)
DK (1) DK335886A (enExample)
ES (1) ES2000346A6 (enExample)
FI (1) FI82929C (enExample)
FR (1) FR2585019B1 (enExample)
GB (2) GB8517923D0 (enExample)
GR (1) GR861840B (enExample)
HU (1) HU198087B (enExample)
IE (1) IE59275B1 (enExample)
IL (1) IL79401A (enExample)
IT (1) IT1213103B (enExample)
NL (1) NL8601838A (enExample)
NO (1) NO169014C (enExample)
NZ (1) NZ216828A (enExample)
PH (1) PH23459A (enExample)
PT (1) PT82985B (enExample)
SE (1) SE468594B (enExample)
SU (2) SU1535378A3 (enExample)
ZA (1) ZA865262B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468642B (sv) * 1985-07-16 1993-02-22 Erba Farmitalia Poly-4-aminopyrrol-2-karboxamidoderivat och foerfarande foer deras framstaellning och en farmaceutisk komposition
GB8612218D0 (en) * 1986-05-20 1986-06-25 Erba Farmitalia Site specific alkylating agents
US5049579A (en) * 1986-05-20 1991-09-17 Farmitalia Carlo Erba, S.R.L. Site specific alkylating agents
US5310752A (en) * 1986-05-20 1994-05-10 Farmitalia Carlo Erba Spa Site specific alkylating agents
GB8906709D0 (en) * 1989-03-23 1989-05-10 Creighton Andrew M Acryloyl substituted pyrrole derivatives
CA2103665C (en) * 1991-02-06 2003-04-15 J. William Lown Oligopeptide antiretroviral agents
IT1262921B (it) * 1992-01-10 1996-07-22 Federico Arcamone Agenti antitumorali analoghi di oligopeptidi pirrol-amidinici retroversi processi di preparazione e prodotti farmaceutici che li contengono
DE4205948C2 (de) * 1992-02-24 1996-10-31 Mannesmann Ag Farbbandkassette für ein endloses Farbband
US5273991A (en) * 1992-07-29 1993-12-28 Research Corporation Technologies, Inc. Imidazole-containing compositions and methods of use thereof analogs of distamycin
US5629348A (en) * 1994-11-14 1997-05-13 Nzym, Inc. Methods and compositions for treating septoria infections
US5637621A (en) * 1994-11-14 1997-06-10 Nzym, Inc. Methods and compositions for treating Botrytis infections
WO1996015104A2 (en) * 1994-11-14 1996-05-23 Nzym, Inc. Methods and compositions for treating phytopathogenic fungi infections
DE19805431A1 (de) * 1998-02-11 1999-08-12 Merck Patent Gmbh Heteroaromatische Oligoamide als Affinitätsliganden
US7078536B2 (en) * 2001-03-14 2006-07-18 Genesoft Pharmaceuticals, Inc. Charged compounds comprising a nucleic acid binding moiety and uses therefor
JP2003529609A (ja) * 2000-03-16 2003-10-07 ジーンソフト インコーポレイティッド 核酸結合部分を含む荷電した化合物およびその利用法
GB0015447D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
ITTO20010633A1 (it) * 2001-07-02 2003-01-02 Univ Ferrara Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale distamicina a.
DE60326735D1 (de) 2002-08-02 2009-04-30 Genesoft Pharmaceuticals Inc Biaryl-verbindungen mit antiinfektiver wirkung
AU2003285958A1 (en) * 2002-10-25 2004-05-25 Genesoft Pharmaceuticals, Inc. Anti-infective biaryl compounds
CA2508769A1 (en) * 2002-12-10 2004-06-24 Oscient Pharmaceuticals Corporation Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
WO2005051318A2 (en) * 2003-11-24 2005-06-09 Viropharma Incorporated Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
CN107683284B (zh) * 2015-03-30 2021-05-11 明治制果药业株式会社 表柔比星的制造方法及其新的制造中间体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA557568A (en) * 1958-05-20 J. Weiss Martin Substituted aminopyrrolecarboxylic acids and esters
CA547128A (en) * 1957-10-08 W. Waller Coy Substituted pyrrolecarboxamidopyrroles
FR86210E (enExample) * 1963-04-04 1966-03-23
BE666612A (enExample) * 1963-07-26 1965-11-03
FR90359E (enExample) * 1963-07-26 1968-02-14
US3420844A (en) * 1963-07-26 1969-01-07 Farmaceutici Italia Pyrrole-2-carboxamido-propionamidines
DE1795539A1 (de) * 1963-07-26 1972-01-13 Farmaceutici Italia Verfahren zur Herstellung von neuen Pyrrolderivaten und ihren Salzen
NL130086C (enExample) * 1964-07-14 1970-06-15
SE468642B (sv) * 1985-07-16 1993-02-22 Erba Farmitalia Poly-4-aminopyrrol-2-karboxamidoderivat och foerfarande foer deras framstaellning och en farmaceutisk komposition
GB8612218D0 (en) * 1986-05-20 1986-06-25 Erba Farmitalia Site specific alkylating agents

Also Published As

Publication number Publication date
GB8617293D0 (en) 1986-08-20
DE3623853C2 (de) 1995-12-21
IE861874L (en) 1987-01-16
JPS6230755A (ja) 1987-02-09
NL8601838A (nl) 1987-02-16
GB2178037B (en) 1989-07-26
AU584723B2 (en) 1989-06-01
FI82929B (fi) 1991-01-31
FI862960L (fi) 1987-01-17
NO169014C (no) 1992-04-29
GB2178037A (en) 1987-02-04
CZ277823B6 (en) 1993-06-16
CS541186A3 (en) 1992-09-16
DE3623853A1 (de) 1987-01-29
FI862960A0 (fi) 1986-07-16
CN86104774A (zh) 1987-02-11
KR870001228A (ko) 1987-03-12
BE905109A (fr) 1987-01-15
PT82985A (pt) 1986-08-01
NO862861L (no) 1987-01-19
CN85103908A (zh) 1986-11-05
US4738980A (en) 1988-04-19
SE8603099L (sv) 1987-01-17
ATA188786A (de) 1988-03-15
IL79401A (en) 1991-05-12
SE468594B (sv) 1993-02-15
JPH0780842B2 (ja) 1995-08-30
SE8603099D0 (sv) 1986-07-11
AT386822B (de) 1988-10-25
HUT41814A (en) 1987-05-28
NZ216828A (en) 1989-11-28
HU198087B (en) 1989-07-28
IT1213103B (it) 1989-12-07
CN1026984C (zh) 1994-12-14
PH23459A (en) 1989-08-07
AU6020386A (en) 1987-01-22
NO169014B (no) 1992-01-20
DK335886D0 (da) 1986-07-15
SU1538893A3 (ru) 1990-01-23
PT82985B (pt) 1989-01-30
FR2585019A1 (fr) 1987-01-23
NO862861D0 (no) 1986-07-15
FR2585019B1 (fr) 1989-07-13
IT8621124A0 (it) 1986-07-15
CH671958A5 (enExample) 1989-10-13
SU1535378A3 (ru) 1990-01-07
GR861840B (en) 1986-11-18
IL79401A0 (en) 1986-10-31
ES2000346A6 (es) 1988-02-16
GB8517923D0 (en) 1985-08-21
IE59275B1 (en) 1994-02-09
FI82929C (fi) 1991-05-10
ZA865262B (en) 1987-03-25
DK335886A (da) 1987-01-17
CA1247627A (en) 1988-12-28

Similar Documents

Publication Publication Date Title
KR940003495B1 (ko) 디스타마이신 a유도체의 제조방법
EP0246868B1 (en) Site specific alkylating agents
JP3121343B2 (ja) ポリ―４―アミノ―２―カルボキシ―１―メチル化合物の新規ウレイド誘導体
FI95463B (fi) Menetelmä anti-tuumoriaineina käyttökelpoisten akryloyylisubstituoitujen pyrrolijohdannaisten valmistamiseksi
HK1006456B (en) Acryloyl substituted pyrrole derivatives
FI83640B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara poly-4-aminopyrrol-2-karboxamidderivat.
MXPA97001949A (en) Derivatives of distamycine substituted with bis- (2-haloethyl) aminophenylene as anatomy agents yantivira
US5049579A (en) Site specific alkylating agents
US5310752A (en) Site specific alkylating agents
JPH05148227A (ja) 抗腫瘍活性を有するヘテロ環式オリゴペプチド
DE19934272A1 (de) Neue antivirale Mittel
WO2001007402A1 (de) Antivirale mittel

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

FPAY Annual fee payment

Payment date: 19970415

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19980424

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19980424